Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 3Thoracic 1Other solid neoplasm 1Myeloid 1Lymphoid 1

Conditions

Mesothelioma, Malignant 57Mesothelioma 35Unspecified Adult Solid Tumor, Protocol Specific 25Solid Tumor 9Advanced Solid Tumors 8Advanced Solid Tumor 7Solitary Fibrous Tumor, Pleural 6Carcinoma, Non-Small-Cell Lung 6Sarcoma 4Lung Neoplasms 4Solid Tumors 3Peritoneal Neoplasms 3Neoplasms 3Stomach Neoplasms 2Retinoblastoma 2Prostatic Neoplasms 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Ovarian Neoplasms 2Neoplasm Metastasis 2Lymphoma, Non-Hodgkin 2Head and Neck Neoplasms 2Extensive Stage Small Cell Lung Cancer 2Colorectal Neoplasms 2Colonic Neoplasms 2Central Nervous System Neoplasms 2Breast Neoplasms 2Advanced Solid Tumour 2Uveal Melanoma 1Uterine Cervical Neoplasms 1Unspecified Childhood Solid Tumor, Protocol Specific 1

Interventions

tislelizumab 1spartalizumab 1ruxolitinib 1niraparib 1entinostat 1avelumab 1Thrombopoietin 1Pemetrexed 1LY2940680 1Injections 1Immunologic Techniques 1Ifosfamide 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Etoposide 1Cisplatin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Uveal Melanoma × Cisplatin × Other solid neoplasm × Clear all
NCT04328844 2026-03-30

A Study to Assess a PI3Kδ Inhibitor (IOA-244) in Patients With Metastatic Cancers

iOnctura

Phase 1 Active not recruiting
210 enrolled
DermatologicLymphoidMyeloidOther solid neoplasmThoracic

Uveal Melanoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Melanoma, Mesothelioma, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡